Literature DB >> 33972288

Covid-19: How will a waiver on vaccine patents affect global supply?

Gareth Iacobucci1.   

Abstract

Entities:  

Year:  2021        PMID： 33972288     DOI： 10.1136/bmj.n1182

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review.

Authors:  Kunmeng Liu; Xiaoming Zhang; Yuanjia Hu; Weijie Chen; Xiangjun Kong; Peifen Yao; Jinyu Cong; Huali Zuo; Jian Wang; Xiang Li; Benzheng Wei
Journal:  Front Med (Lausanne)       Date:  2022-07-01

2.  The COVID-19 vaccine patent: a right without rationale.

Authors:  Nabeel Mahdi Althabhawi; Ali Adil Kashef Al-Ghetaa
Journal:  Med Humanit       Date:  2022-05-06

3.  Rethinking the International Response System to Global Health Threats: Strengthening International Collaboration to Ensure Vaccine Equity and Combat Vaccination Hesitancy.

Authors:  Ramin Walter Parsa-Parsi
Journal:  South Med J       Date:  2022-03       Impact factor: 0.954

4.  What's yours is ours: waiving intellectual property protections for COVID-19 vaccines.

Authors:  Nancy S Jecker; Caesar A Atuire
Journal:  J Med Ethics       Date:  2021-07-07       Impact factor: 2.903

5.  Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching.

Authors:  Vivencio O Ballano
Journal:  Linacre Q       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.